Medicine quality – a global concern

There is growing, belated, concern about the manufacturing, trafficking and sale of fake and illicit medicines and medical devices. Poor quality medicines undermine public health systems' effectiveness and patients' confidence in health care delivery systems. Fake and illicit medicines that patients actually take contain incorrect amounts or no active ingredients at all. This serious gap in public health causes avoidable morbidity, mortality, and antibiotic resistance.
Legislation and definitions for poor quality medicines are heterogeneous across countries, although there are initiatives that aim to harmonize them.

Why do definitions and effective legislation on medicine quality matter?

Criminals are not hindered by borders, often they take advantage of insufficient international collaboration and poor or nonexistent national legislation. Strong national and international laws are needed to address the growing problem of fake and illicit medical products which have an increasingly international dimension.

Creating an interactive map of relevant national legislation

Collaboration between enforcement and national medicine regulatory authorities is key to detect, disrupt and prosecute perpetrators of pharmaceutical crimes.

This interactive map aims to serve as a tool for the law enforcement and medicine regulation communities to access existing legislation on pharmaceutical crime in different countries and, where needed, extract ideas and inspiration to introduce changes in their national legislation to more effectively be able to combat pharmaceutical crime.

The map currently covers legislation of a variety of countries from different regions of the world and we are continuously working to expand the number of countries included.

Contact WWARN

Feel free to email us to provide some feedback on this website, give us suggestions for new content or notify us of omissions, or to just say hello!